Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for Chronic Kidney Disease-Mineral and Bone Disorder
- Neutrophil Gelatinase-associated Lipocalin VS Vascular Calcification in Maintenance Hemodialysis Patients
- PRevEnting FracturEs in Renal Disease - 1
- Injection of Teriparatide to Prevent Hypocalcemia After Parathyroidectomy in Dialysis Patients (TeriCa).
- Treatment of Adynamic Bone Disorder With Parathyroid Hormone in Chronic Kidney Disease
- The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients
- The Effect of Etelcalcetide on CKD-MBD
- Renal Osteodystrophy: An Individual Management Approach
- Zoledronic Acid to Prevent Bone Loss After Kidney Transplantation
- Kidney Yin/Yang Replenishment on Patients With Renal Osteodystrophy
- Efficacy of Vitamin D2 to Treat Chronic Kidney Disease Mineral and Bone Disorder
- Open-label Study to Assess the Long-term Safety and Efficacy of Etelcalcetide (Also Known as AMG 416 or KAI-4169) in Patients With Secondary Hyperparathyroidism
- Etelcalcetide to Treat Secondary Hyperparathyroidism in Hemodialysis Patients With Chronic Kidney Disease-Mineral and Bone Disorder
- Vitamin D3 Substitution in Vitamin D Deficient Kidney Transplant Recipients
- Regulation of Bone Formation in Renal Osteodystrophy
- 12-month Study of AMG 073 in Renal Osteodystrophy
- Cholecalciferol Versus Doxercalciferol in the Treatment of Secondary Hyperparathyroidism in Chronic Kidney Disease
- Osteopenia and Renal Osteodystrophy: Evaluation and Management
- Phase II Randomized Study of the Effects of Growth Hormone on Children and Adolescents on Maintenance Dialysis